Appendix
Workshop Agenda
INSTITUTE OF MEDICINE
National Academy of Sciences
Board on International Health
Board on Health Promotion and Disease Prevention
Workshop on Malaria Vaccines
19–20 October 1995
Cecil and Ida Green Building, Room 104
2001 Wisconsin Avenue, N.W.
Washington, DC 20007
(202) 334-3904
AGENDA
19 October 1995
8:30 a.m.–8:45 a.m. |
Welcome and Introductions |
Philip Russell, Chair, IOM Committee on Malaria Vaccines |
8:45 a.m.–10:45 a.m. |
SESSION I: SETTING THE STAGE |
(8:45 a.m.–9:15 a.m.) |
Malaria: The Deteriorating Situation |
Donald Krogstad, Tulane University School of Public Health and Tropical Medicine, USA |
|
(9:15 a.m.–9:45 a.m.) |
The Promise of Malaria Vaccines |
Jerald Sadoff, Merck Research Laboratories, USA |
(9:45 a.m.–10:05 a.m.) |
Malaria Vaccines in the Field: A Perspective from the Africa Malaria Vaccine Testing Network |
Wenceslaus Kilama, The African Malaria Vaccine Testing Network, Tanzania |
|
(10:05 a.m.–10:30 a.m.) |
Discussion |
Moderator: Philip Russell |
|
10:30 a.m.–11:00 a.m. |
Break |
11:00 a.m.–12:00 p.m. |
SESSION II: MALARIA AS A PARADIGM |
Stephen Hoffman, Naval Medical Research Institute, USA |
|
(11:40 a.m.–12:00 p.m.) |
Discussion |
Moderator: Louis Miller, National Institutes of Health, USA |
|
12:00 p.m.–1:00 p.m. |
Lunch |
1:00 p.m.–3:30 p.m. |
SESSION III: CURRENT APPROACHES TO MALARIA VACCINE DEVELOPMENT |
(1:00 p.m.–1:25 p.m.) |
Preerythrocytic Vaccines |
Ruth Nussenzweig, New York University Medical Center, USA |
|
(5 min.) |
Questions |
(1:30 p.m.–1:55 p.m.) |
Erythrocytic Vaccines |
Graham Brown, The Walter and Eliza Hall Institute of Medical Research, Australia |
|
(5 min.) |
Questions |
(2:00 p.m.–2:25 p.m.) |
Transmission Blocking Vaccines |
David Kaslow, National Institutes of Health, USA |
|
(5 min.) |
Questions |
(2:30 p.m.–3:30 p.m.) |
Discussion: Potential Immunologic Obstacles toDevelopment of an Optimal Multi-Immune Response, Multi-Stage Malaria Vaccine |
Moderator: W. R. Ballou, Walter Reed Army Institute of Research, USA |
|
3:30 p.m.–4:00 p.m. |
Break |
4:00 p.m.–5:30 p.m. |
SESSION IV: ROUNDTABLE ON U.S. FEDERAL MALARIA VACCINE ACTIVITIES |
Summary of Agency Activities
20 October 1995
(4:00 p.m.–4:15 p.m.) |
Public Health Service |
Daniel Colley, Centers for Disease Control and Prevention |
|
(4:15 p.m.–4:30 p.m.) |
Department of Defense |
William Bancroft, U.S. Army Medical Research and Materiel Command |
|
(4:30 p.m.–4:45 p.m.) |
U.S. Agency for InternationalDevelopment |
Carter Diggs, USAID |
|
(4:45 p.m.–5:00 p.m.) |
Federal Malaria Vaccine Coordinating Committee |
Lee Hall, National Institutes of Health |
|
(5:00 p.m.–5:30 p.m.) |
Roundtable Discussion |
Moderator: Lee Hall |
|
5:30 p.m. |
Reception (North Prefunction Area, directly outside meeting room) |
8:30 a.m.–10:15 a.m. |
SESSION V: ROUNDTABLE ON INDUSTRIAL SECTOR ACTIVITIES |
(8:30 a.m.–9:00 a.m.) |
Malaria Vaccine Development: A Perspective from Industry |
Russell Howard, Glaxo-Wellcome |
|
(9:00 a.m.–9:35 a.m.) |
The following participants may wish to present for 5 min. each: |
Ian Bathurst, LXR Biotechnology W. Neal Burnette, Molecular Pharmaceutics Corporation Kenneth Guito, Connaught Laboratories Maurice Hilleman, The Merck Institute Adeoye Olukotun, Bristol-Myers Squibb Company John Tine, Virogenetics Corporation |
(9:35 a.m.–10:15 a.m.) |
Roundtable Discussion |
Moderator: Russell Howard |
|
10:15 a.m.–10:45 a.m. |
Break |
10:45 a.m.–12:15 a.m. |
SESSION VI: ROUNDTABLE ON INTERNATIONAL COLLABORATION |
(10:45 a.m.–11:00 a.m.) |
Overview of Global Malaria Vaccine Activities |
Howard Engers, WHO Special Programme for Research and Training in Tropical Diseases, Switzerland |
|
(11:00 a.m.–11:15 a.m.) |
DANIDA and Commission of European Communities |
Palle Jakobsen, Denmark |
|
(11:15 a.m.–11:25 a.m.) |
African Malaria Vaccine Testing Network |
Wenceslaus Kilama, Tanzania |
|
(11:25 a.m.–11:35 a.m.) |
Walter and Eliza Hall Institute of Medical Research |
Graham Brown, Australia |
|
(11:35 a.m.–11:45 a.m.) |
Medical Research Council |
Michael Davies, Great Britain |
|
(11:45 a.m.–12:15 p.m.) |
Roundtable Discussion |
Moderator: Howard Engers (session will include participants from the Roundtable on U.S. Federal Malaria Vaccine Activities) |
12:15 p.m.–1:00 p.m. |
SESSION VII: SUMMARY AND DISCUSSION OF FINDINGS, CONCLUSIONS, AND RECOMMENDATIONS |
Philip Russell, IOM Committee Chair |
|
1:00 p.m. |
Workshop Adjournment |
1:30 p.m.–5:00 p.m. |
EXECUTIVE SESSION |
Workshop Committee on Malaria Vaccines |